Bunge Limited (BG) | Financial Analysis & Statements
Bunge Limited Large-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
23.8B
Gross Profit
1.0B
4.25%
Operating Income
374.0M
1.57%
Net Income
88.0M
0.37%
EPS (Diluted)
$0.49
Balance Sheet Metrics
Total Assets
44.5B
Total Liabilities
27.1B
Shareholders Equity
17.4B
Debt to Equity
1.56
Cash Flow Metrics
Operating Cash Flow
770.0M
Free Cash Flow
809.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Bunge Limited Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 70.3B | 53.1B | 59.5B | 67.2B | 59.2B |
| Cost of Goods Sold | 66.9B | 49.7B | 54.7B | 63.6B | 55.8B |
| Gross Profit | 3.4B | 3.4B | 4.8B | 3.7B | 3.4B |
| Gross Margin % | 4.8% | 6.4% | 8.1% | 5.5% | 5.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 2.1B | 1.8B | 1.7B | 1.4B | 1.2B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 2.1B | 1.8B | 1.7B | 1.4B | 1.2B |
| Operating Income | 1.3B | 1.6B | 3.1B | 2.3B | 2.1B |
| Operating Margin % | 1.8% | 3.0% | 5.3% | 3.4% | 3.6% |
| Non-Operating Items | |||||
| Interest Income | 202.0M | 163.0M | 148.0M | 71.0M | 48.0M |
| Interest Expense | 628.0M | 471.0M | 516.0M | 403.0M | 243.0M |
| Other Non-Operating Income | 264.0M | 215.0M | 289.0M | 85.0M | 631.0M |
| Pre-tax Income | 1.1B | 1.5B | 3.1B | 2.1B | 2.6B |
| Income Tax | 288.0M | 336.0M | 714.0M | 388.0M | 398.0M |
| Effective Tax Rate % | 25.4% | 22.0% | 23.4% | 18.8% | 15.5% |
| Net Income | 843.0M | 1.2B | 2.3B | 1.7B | 2.2B |
| Net Margin % | 1.2% | 2.2% | 3.9% | 2.5% | 3.7% |
| Key Metrics | |||||
| EBITDA | 2.5B | 2.7B | 4.0B | 2.9B | 3.3B |
| EPS (Basic) | $4.95 | $8.49 | $15.07 | $10.74 | $14.49 |
| EPS (Diluted) | $4.91 | $7.99 | $14.87 | $10.51 | $13.64 |
| Basic Shares Outstanding | 165042767 | 133964235 | 148804387 | 149907932 | 141057414 |
| Diluted Shares Outstanding | 165042767 | 133964235 | 148804387 | 149907932 | 141057414 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Bunge Limited Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.1B | 3.3B | 2.6B | 1.1B | 902.0M |
| Short-term Investments | 1.1B | 484.0M | 105.0M | 119.0M | 520.0M |
| Accounts Receivable | 3.9B | 2.1B | 2.6B | 2.8B | 2.1B |
| Inventory | 13.2B | 6.5B | 7.1B | 8.4B | 8.4B |
| Other Current Assets | 482.0M | 434.0M | 265.0M | 386.0M | 198.0M |
| Total Current Assets | 24.4B | 16.0B | 16.4B | 16.8B | 16.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.7B | 932.0M | 926.0M | 1.0B | 912.0M |
| Goodwill | 6.6B | 1.2B | 1.4B | 1.3B | 1.4B |
| Intangible Assets | 309.0M | 321.0M | 398.0M | 360.0M | 431.0M |
| Long-term Investments | 8.0M | 0 | 1.0M | 1.0M | 49.0M |
| Other Non-Current Assets | 1.7B | 1.0B | 1.2B | 1.2B | 1.0B |
| Total Non-Current Assets | 20.1B | 8.9B | 9.0B | 7.8B | 7.4B |
| Total Assets | 44.5B | 24.9B | 25.4B | 24.6B | 23.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 4.9B | 2.8B | 3.7B | 4.4B | 4.2B |
| Short-term Debt | 5.9B | 1.8B | 1.1B | 1.8B | 1.5B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.9B | 1.3B | 1.3B | 1.9B | 2.3B |
| Total Current Liabilities | 15.1B | 7.4B | 7.7B | 9.6B | 9.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 9.9B | 5.3B | 4.6B | 3.8B | 5.3B |
| Deferred Tax Liabilities | 988.0M | 379.0M | 400.0M | 365.0M | 338.0M |
| Other Non-Current Liabilities | 212.0M | 164.0M | 176.0M | 160.0M | 195.0M |
| Total Non-Current Liabilities | 12.0B | 6.5B | 5.9B | 5.0B | 6.3B |
| Total Liabilities | 27.1B | 14.0B | 13.6B | 14.6B | 15.6B |
| Equity | |||||
| Common Stock | 2.0M | 1.0M | 0 | 1.0M | 1.0M |
| Retained Earnings | 13.2B | 12.8B | 12.1B | 10.2B | 9.0B |
| Treasury Stock | 1.0B | 1.5B | 1.1B | 1.3B | 1.1B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 17.4B | 10.9B | 11.8B | 10.0B | 8.2B |
| Key Metrics | |||||
| Total Debt | 15.9B | 7.1B | 5.8B | 5.6B | 6.8B |
| Working Capital | 9.3B | 8.5B | 8.7B | 7.2B | 7.1B |
Balance Sheet Composition
Bunge Limited Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 843.0M | 1.2B | 2.3B | 1.7B | 2.2B |
| Depreciation & Amortization | 703.0M | 468.0M | 451.0M | 408.0M | 424.0M |
| Stock-Based Compensation | 73.0M | 65.0M | 69.0M | 65.0M | 61.0M |
| Working Capital Changes | -677.0M | 426.0M | 1.7B | -7.7B | -5.0B |
| Operating Cash Flow | 1.0B | 2.2B | 4.7B | -5.6B | -2.6B |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -3.2B | 675.0M | 34.0M | 453.0M | 601.0M |
| Investment Purchases | -3.1B | -1.3B | -133.0M | -456.0M | -342.0M |
| Investment Sales | 2.8B | 958.0M | 49.0M | 326.0M | 171.0M |
| Investing Cash Flow | -3.5B | 262.0M | 113.0M | 7.1B | 5.5B |
| Financing Activities | |||||
| Share Repurchases | -551.0M | -1.1B | -600.0M | -200.0M | -100.0M |
| Dividends Paid | -459.0M | -378.0M | -383.0M | -349.0M | -323.0M |
| Debt Issuance | 3.6B | 2.0B | 978.0M | 297.0M | 1.0B |
| Debt Repayment | -3.7B | -1.8B | -2.2B | -2.9B | -4.6B |
| Financing Cash Flow | 902.0M | -1.2B | -1.9B | -2.7B | -6.4B |
| Free Cash Flow | -879.0M | 524.0M | 2.2B | -6.1B | -3.3B |
| Net Change in Cash | -1.6B | 1.3B | 3.0B | -1.2B | -3.5B |
Cash Flow Trend
Bunge Limited Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
25.51
Forward P/E
11.98
Price to Book
1.53
Price to Sales
0.35
PEG Ratio
-0.29
Profitability Ratios
Profit Margin
1.16%
Operating Margin
1.26%
Return on Equity
5.96%
Return on Assets
2.51%
Financial Health
Current Ratio
1.61
Debt to Equity
91.01
Beta
0.70
Per Share Data
EPS (TTM)
$4.93
Book Value per Share
$82.23
Revenue per Share
$426.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BG | 24.5B | 25.51 | 1.53 | 5.96% | 1.16% | 91.01 |
| Archer-Daniels-Midla | 33.4B | 31.04 | 1.46 | 4.72% | 1.34% | 42.38 |
| Tyson Foods | 22.5B | 116.48 | 1.27 | 1.26% | 0.36% | 46.04 |
| Smithfield Foods | 11.5B | 11.67 | 1.69 | 15.21% | 6.36% | 33.91 |
| Cal-Maine Foods | 3.6B | 5.36 | 1.35 | 27.30% | 20.07% | 0.00 |
| Fresh Del Monte | 2.0B | 21.76 | 0.96 | 4.63% | 2.10% | 17.19 |
Financial data is updated regularly. All figures are in the company's reporting currency.






